Effect of Liver Disease on Hepatic Transporter Expression and Function.
about
Transporter-mediated Alterations in Patients with NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.Organic Solute Transporter OSTα/ß is Over-Expressed in Nonalcoholic Steatohepatitis and Modulated by Drugs Associated with Liver Injury.Pharmacokinetics, safety, and tolerability of the 2- and 3-direct-acting antiviral combination of AL-335, odalasvir, and simeprevir in healthy subjects.
P2860
Effect of Liver Disease on Hepatic Transporter Expression and Function.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Effect of Liver Disease on Hepatic Transporter Expression and Function.
@en
type
label
Effect of Liver Disease on Hepatic Transporter Expression and Function.
@en
prefLabel
Effect of Liver Disease on Hepatic Transporter Expression and Function.
@en
P2860
P1476
Effect of Liver Disease on Hepatic Transporter Expression and Function.
@en
P2093
Jason R Slizgi
Nilay Thakkar
P2860
P304
P356
10.1016/J.XPHS.2017.04.053
P407
P50
P577
2017-04-29T00:00:00Z